4//SEC Filing
Mathew Aby J. 4
Accession 0001628280-25-054278
CIK 0000834365other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 5:35 PM ET
Size
5.0 KB
Accession
0001628280-25-054278
Insider Transaction Report
Form 4
Mathew Aby J.
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-11-25$26.74/sh−526$14,065→ 350,386 total
Footnotes (1)
- [F1]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001556355
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 5:35 PM ET
- Size
- 5.0 KB